• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾衰竭中的药代动力学扰动。代谢物和组织扩散异常(作者译)]

[Pharmacokinetic perturbations in kidney failure. Anomalies of metabolites and tissue diffusion (author's transl)].

作者信息

Fabre J, Balant L, Rudhardt M, Blanchard P

出版信息

Nouv Presse Med. 1979;8(33):2677-82.

PMID:114976
Abstract

Complex pharmacokinetic perturbations follow kidney failure. Delayed excretion affects not only the original substance but also metabolites, as illustrated by the behaviour of glipizide and glibenclamide. Moreover, abnormal absorption, distribution, and metabolism of these drugs also often occur and are particularily evident for some beta-blocking agents. Analysis of tissue pharmacokinetics shows that aminosides accumulate in the renal cortexand persist there for several months. This phenomenon is markedly enhanced in acute obstructive kidney failure and largely accounts for the nephrotoxicity of these drugs.

摘要

肾衰竭会引发复杂的药代动力学紊乱。排泄延迟不仅会影响原物质,还会影响代谢产物,格列吡嗪和格列本脲的情况就说明了这一点。此外,这些药物还常常出现吸收、分布及代谢异常,这在某些β受体阻滞剂中尤为明显。组织药代动力学分析表明,氨基糖苷类药物会在肾皮质中蓄积,并在那里持续存在数月。这种现象在急性梗阻性肾衰竭中会显著增强,这也是这些药物具有肾毒性的主要原因。

相似文献

1
[Pharmacokinetic perturbations in kidney failure. Anomalies of metabolites and tissue diffusion (author's transl)].[肾衰竭中的药代动力学扰动。代谢物和组织扩散异常(作者译)]
Nouv Presse Med. 1979;8(33):2677-82.
2
Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.格列本脲和格列吡嗪,第二代口服磺酰脲类降糖药。
Clin Pharm. 1984 Sep-Oct;3(5):473-85.
3
Aminoglycoside renal cortical kinetics: a clue to mechanisms of nephrotoxicity.氨基糖苷类药物在肾皮质的动力学:肾毒性机制的线索
Prog Clin Biol Res. 1979;35:33-41.
4
[Aminoglycoside nephrotoxicity. I. Clinical aspects, morphology and tissue pharmacokinetics].[氨基糖苷类肾毒性。I. 临床方面、形态学及组织药代动力学]
Nephrologie. 1980;1(1):37-43.
5
Study on pulmonary, prostatic and renal (medulla and cortex) distribution of sagamicin at different time intervals.不同时间间隔下相模霉素在肺、前列腺及肾(髓质和皮质)中的分布研究。
Int J Clin Pharmacol Res. 1987;7(1):51-8.
6
Kinetics of the renal cortical uptake and release of aminoglycosides: a rational approach to the understanding and prevention of their nephrotoxicity.氨基糖苷类药物在肾皮质的摄取与释放动力学:理解和预防其肾毒性的合理方法。
Dev Toxicol Environ Sci. 1986;14:105-14.
7
Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and prevention.
Contrib Nephrol. 1984;42:182-95.
8
[Prediction of aminoglycoside nephrotoxicity (author's transl)].氨基糖苷类肾毒性的预测(作者译)
Nouv Presse Med. 1978 Nov 29;7(42):3838-43.
9
Aminoglycoside nephrotoxicity--a tale of two transports.氨基糖苷类肾毒性——两种转运机制的故事
J Lab Clin Med. 1982 Feb;99(2):148-55.
10
[Prevision of aminoglycoside nephrotoxicity (author's transl)].
Pathol Biol (Paris). 1982 Apr;30(4):227-31.

引用本文的文献

1
Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.磺酰脲类降糖药物的临床药代动力学
Clin Pharmacokinet. 1981 May-Jun;6(3):215-41. doi: 10.2165/00003088-198106030-00003.
2
Pharmacokinetics of mepindolol in patients with chronic renal failure.美吲哚洛尔在慢性肾衰竭患者中的药代动力学
Eur J Clin Pharmacol. 1984;27(4):429-33. doi: 10.1007/BF00549590.
3
Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.
药物动力学特性的差异:对肾衰竭患者选用特定药物的意义,特别强调抗生素和β-肾上腺素能受体阻滞剂。
Clin Pharmacokinet. 1980 Sep-Oct;5(5):441-64. doi: 10.2165/00003088-198005050-00003.